GNRSU stock down 99.999% to $0.00 in market hours: heavy downside for PNK holders

GNRSU stock plunged to $0.00 (actual USD 1e-06) on 30 Mar 2026 during market hours after a -99.999% one-day move. The Greenrose Holding Company Inc. (GNRSU) on the PNK exchange in the United States traded just 145 shares at the low, leaving the market cap at roughly $13.00. This sharp collapse followed a previous close of $0.15, producing an outsized price gap that traders and shareholders must address immediately. We examine the price drivers, financial ratios, Meyka AI grade, and a model forecast for GNRSU stock to highlight risk and potential scenarios.

GNRSU stock collapse: price action, volume and immediate drivers

GNRSU stock fell from $0.15 previous close to $0.00 (actual USD 1e-06) in market hours on 30 Mar 2026, a -99.999% change with 145 shares traded. The abrupt move erased nearly all quoted liquidity and pushed the intraday spread to effectively nil. Market participants cite extremely low trading volume and thin OTC liquidity on the PNK exchange as primary causes for the amplified move.

The intraday profile shows a day low and day high both at USD 0.000001 on the quote feed, indicating a technical collapse rather than new fundamental disclosure. Investors should treat this as a liquidity-driven event unless the company releases material news.

GNRSU stock fundamentals: key metrics and what they tell investors

The Greenrose Holding Company Inc. (GNRSU) reports EPS 3.10 and a trailing book value per share of 4.30, with shares outstanding 12,853,627 and full-time employees 910. Reported TTM metrics show operating cash flow per share 0.51 and free cash flow per share 0.16, but the balance sheet shows negative working capital and a high interest-debt-per-share figure of 6.90.

Key ratios include a current ratio of 0.21 and debt to equity of 1.57, which indicate liquidity strain if operational cash flow weakens. The year high sits at $0.15, making the present quoted price an outlier driven by microcap liquidity.

Meyka AI rates GNRSU with a score out of 100

Meyka AI rates GNRSU with a score out of 100: 66.81, Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score balances pockets of positive profitability metrics against liquidity and enterprise value oddities.

DISCLAIMER: These grades are informational only and not financial advice. Please conduct your own research before making investment decisions.

GNRSU stock technicals and trading context on PNK

Technical indicators are limited by low volume; average volume data is not available and short-term averages (50-day, 200-day) sit at $0.15. The asset trades on the PNK exchange in the United States with quoted market cap $13.00 and enterprise value metrics that appear distorted by the near-zero price.

Given the quote distortion, commonly used technical signals (moving averages, RSI) are unreliable until normal volume returns or the company provides clear corporate action guidance.

GNRSU stock outlook and Meyka AI forecast

Meyka AI’s forecast model projects a recovery reference price of $0.05, compared with current price USD 1e-06, implying a theoretical upside of +4,999,900.00% if liquidity and fundamentals normalize. Forecasts are model-based projections and not guarantees. The model assumes restoration of tradable shares and improved operational cash flow trends.

Near-term outlook depends on corporate disclosures, OTC liquidity restoration, and sector dynamics in Healthcare and Drug Manufacturers – Specialty & Generic. Investors should watch official company releases and filings closely.

GNRSU stock risks and catalysts to monitor

Immediate risks include continued illiquidity, potential delisting risk on public quotation venues, and balance-sheet pressure driven by negative working capital of -$103,434,000.00 (TTM metric). Inventory turnover sits at 0.83, suggesting product build rather than rapid sell-through.

Catalysts that could change the trajectory are a company-led restructuring, reverse splits to restore price measurability, fresh capital injections, or legally required disclosures. Check the company website and filings for any material updates: Greenrose Holding Company and profile data at FinancialModelingPrep GNRSU.

Final Thoughts

Key takeaways for GNRSU stock on 30 Mar 2026: the price quote collapsed to $0.00 (actual USD 1e-06) in market hours, driven largely by extreme OTC illiquidity and sparse volume (145 shares). Fundamentals show pockets of profitability per share metrics (EPS 3.10, book value per share 4.30), but the balance sheet and cash ratios signal near-term liquidity stress. Meyka AI rates GNRSU with a 66.81 score out of 100 (Grade B, Suggestion HOLD) and flags the valuation distortion caused by the quote collapse. Meyka AI’s forecast model projects $0.05, compared with current price USD 1e-06, implying a model-based upside of +4,999,900.00% if liquidity and corporate actions restore tradability; forecasts are model-based projections and not guarantees. For traders and investors, the dominant risk is microcap liquidity and quote reliability on the PNK exchange. Monitor company disclosures, OTC trading notices, and sector moves in Healthcare for confirmation before repositioning. Meyka AI provides this as AI-powered market analysis but this is not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.